NAPM GENERIC DRUG USER FEE TASK FORCE HOPES TO HAVE A PROPOSAL FOR FDA TO CONSIDER BY EARLY MARCH; NPA, GPIA HAVE NOT YET DECIDED TO PURSUE USER FEES
Executive Summary
The National Association of Pharmaceutical Manufacturers hopes to have a generic drug user fee proposal for its leadership to take to FDA in about a month.